Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Mov Disord. 2015 Oct 7;31(6):915–923. doi: 10.1002/mds.26438

Figure 1. Number of unique samples available in the NINDS bioropository as of 10/21/2014.

Figure 1

DNA is collected once, primarily at the baseline visit but in some cases at the 6 or 12 month visit RNA is drawn at least once on almost every participant and repeatedly for some participants. About two-thirds of the participants have baseline whole blood, serum and plasma available and about one quarter of the participants have baseline CSF available. As participants return for longitudinal assessments, there will be increased availability of biofluids from those visits.